127 related articles for article (PubMed ID: 12824022)
1. 4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs.
Manetti D; Martini E; Ghelardini C; Dei S; Galeotti N; Guandalini L; Romanelli MN; Scapecchi S; Teodori E; Bartolini A; Gualtieri F
Bioorg Med Chem Lett; 2003 Jul; 13(14):2303-6. PubMed ID: 12824022
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents.
Manetti D; Ghelardini C; Bartolini A; Bellucci C; Dei S; Galeotti N; Gualtieri F; Romanelli MN; Scapecchi S; Teodori E
J Med Chem; 2000 May; 43(10):1969-74. PubMed ID: 10821709
[TBL] [Abstract][Full Text] [Related]
3. Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs.
Guandalini L; Martini E; Di Cesare Mannelli L; Dei S; Manetti D; Scapecchi S; Teodori E; Ghelardini C; Romanelli MN
Bioorg Med Chem Lett; 2012 Mar; 22(5):1936-9. PubMed ID: 22325944
[TBL] [Abstract][Full Text] [Related]
4. Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.
Guandalini L; Martino MV; Di Cesare Mannelli L; Bartolucci G; Melani F; Malik R; Dei S; Floriddia E; Manetti D; Orlandi F; Teodori E; Ghelardini C; Romanelli MN
Bioorg Med Chem Lett; 2015 Apr; 25(8):1700-1704. PubMed ID: 25813160
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers.
Martini E; Ghelardini C; Dei S; Guandalini L; Manetti D; Melchiorre M; Norcini M; Scapecchi S; Teodori E; Romanelli MN
Bioorg Med Chem; 2008 Feb; 16(3):1431-43. PubMed ID: 17981042
[TBL] [Abstract][Full Text] [Related]
6. Cognitive-enhancing activity of loganin isolated from Cornus officinalis in scopolamine-induced amnesic mice.
Lee KY; Sung SH; Kim SH; Jang YP; Oh TH; Kim YC
Arch Pharm Res; 2009 May; 32(5):677-83. PubMed ID: 19471881
[TBL] [Abstract][Full Text] [Related]
7. Design of new cognition enhancers: from computer prediction to synthesis and biological evaluation.
Geronikaki AA; Dearden JC; Filimonov D; Galaeva I; Garibova TL; Gloriozova T; Krajneva V; Lagunin A; Macaev FZ; Molodavkin G; Poroikov VV; Pogrebnoi SI; Shepeli F; Voronina TA; Tsitlakidou M; Vlad L
J Med Chem; 2004 May; 47(11):2870-6. PubMed ID: 15139765
[TBL] [Abstract][Full Text] [Related]
8. AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram).
Galeotti N; Ghelardini C; Pittaluga A; Pugliese AM; Bartolini A; Manetti D; Romanelli MN; Gualtieri F
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):538-45. PubMed ID: 14600801
[TBL] [Abstract][Full Text] [Related]
9. Reversal of scopolamine-induced amnesia by the GABAB receptor antagonist CGP 35348 in the mouse.
Bianchi M; Panerai AE
Brain Res Cogn Brain Res; 1993 Apr; 1(2):135-6. PubMed ID: 8390321
[TBL] [Abstract][Full Text] [Related]
10. Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents.
Martino MV; Guandalini L; Di Cesare Mannelli L; Menicatti M; Bartolucci G; Dei S; Manetti D; Teodori E; Ghelardini C; Romanelli MN
Bioorg Med Chem; 2017 Mar; 25(6):1795-1803. PubMed ID: 28238510
[TBL] [Abstract][Full Text] [Related]
11. Chronic exposure of rats to cognition enhancing drugs produces a neuroplastic response identical to that obtained by complex environment rearing.
Murphy KJ; Foley AG; O'connell AW; Regan CM
Neuropsychopharmacology; 2006 Jan; 31(1):90-100. PubMed ID: 15988469
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments.
Mansouri MT; Farbood Y; Naghizadeh B; Shabani S; Mirshekar MA; Sarkaki A
Pharm Biol; 2016 Oct; 54(10):1947-53. PubMed ID: 26828763
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers.
Martini E; Salvicchi A; Ghelardini C; Manetti D; Dei S; Guandalini L; Martelli C; Melchiorre M; Cellai C; Scapecchi S; Teodori E; Romanelli MN
Bioorg Med Chem; 2009 Nov; 17(21):7606-14. PubMed ID: 19786353
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers.
Pinza M; Farina C; Cerri A; Pfeiffer U; Riccaboni MT; Banfi S; Biagetti R; Pozzi O; Magnani M; Dorigotti L
J Med Chem; 1993 Dec; 36(26):4214-20. PubMed ID: 8277504
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of some quinoline derivatives as potential cognition enhancers.
Piplani P; Rani A; Saihgal R; Sharma M
Arzneimittelforschung; 2011; 61(7):373-8. PubMed ID: 21899203
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugs.
Martini E; Di Cesare Mannelli L; Bartolucci G; Bertucci C; Dei S; Ghelardini C; Guandalini L; Manetti D; Scapecchi S; Teodori E; Romanelli MN
J Med Chem; 2011 Apr; 54(7):2512-6. PubMed ID: 21381762
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator.
Ward SE; Beswick P; Calcinaghi N; Dawson LA; Gartlon J; Graziani F; Jones DN; Lacroix L; Selina Mok MH; Oliosi B; Pardoe J; Starr K; Woolley ML; Harries MH
Br J Pharmacol; 2017 Mar; 174(5):370-385. PubMed ID: 28009436
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.
Martini E; Norcini M; Ghelardini C; Manetti D; Dei S; Guandalini L; Melchiorre M; Pagella S; Scapecchi S; Teodori E; Romanelli MN
Bioorg Med Chem; 2008 Dec; 16(23):10034-42. PubMed ID: 18954993
[TBL] [Abstract][Full Text] [Related]
19. Cognitive enhancing effects of alpha asarone in amnesic mice by influencing cholinergic and antioxidant defense mechanisms.
Kumar H; Kim BW; Song SY; Kim JS; Kim IS; Kwon YS; Koppula S; Choi DK
Biosci Biotechnol Biochem; 2012; 76(8):1518-22. PubMed ID: 22878197
[TBL] [Abstract][Full Text] [Related]
20. Antiamnesic effect of metoprine and of selective histamine H(1) receptor agonists in a modified mouse passive avoidance test.
Malmberg-Aiello P; Ipponi A; Bartolini A; Schunack W
Neurosci Lett; 2000 Jul; 288(1):1-4. PubMed ID: 10869801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
